Genetic clues to the pathogenesis of Parkinson's disease - PubMed (original) (raw)

Review

. 2004 Jul:10 Suppl:S58-62.

doi: 10.1038/nm1068.

Affiliations

• PMID: 15272270
• DOI: 10.1038/nm1068

Review

Genetic clues to the pathogenesis of Parkinson's disease

Miquel Vila et al. Nat Med. 2004 Jul.

Abstract

Recent years have seen an explosion in the rate of discovery of genetic defects linked to Parkinson's disease. These breakthroughs have not provided a direct explanation for the disease process. Nevertheless, they have helped transform Parkinson's disease research by providing tangible clues to the neurobiology of the disorder.

PubMed Disclaimer

Similar articles

• Biomedicine. Parkinson's--divergent causes, convergent mechanisms.
  Greenamyre JT, Hastings TG. Greenamyre JT, et al. Science. 2004 May 21;304(5674):1120-2. doi: 10.1126/science.1098966. Science. 2004. PMID: 15155938 No abstract available.
• Impact of genetic analysis on Parkinson's disease research.
  Hardy J. Hardy J. Mov Disord. 2003 Sep;18 Suppl 6:S96-8. doi: 10.1002/mds.10569. Mov Disord. 2003. PMID: 14502662 Review.
• [The genetics of Parkinson disease].
  Toft M, Aasly J. Toft M, et al. Tidsskr Nor Laegeforen. 2004 Apr 1;124(7):922-4. Tidsskr Nor Laegeforen. 2004. PMID: 15060636 Review. Norwegian.
• Rare genetic mutations shed light on the pathogenesis of Parkinson disease.
  Dawson TM, Dawson VL. Dawson TM, et al. J Clin Invest. 2003 Jan;111(2):145-51. doi: 10.1172/JCI17575. J Clin Invest. 2003. PMID: 12531866 Free PMC article. Review. No abstract available.
• New genetic insights into Parkinson's disease.
  Feany MB. Feany MB. N Engl J Med. 2004 Nov 4;351(19):1937-40. doi: 10.1056/NEJMp048263. N Engl J Med. 2004. PMID: 15525720 No abstract available.

Cited by

• Proteomics in neurodegeneration--disease driven approaches.
  Schulenborg T, Schmidt O, van Hall A, Meyer HE, Hamacher M, Marcus K. Schulenborg T, et al. J Neural Transm (Vienna). 2006 Aug;113(8):1055-73. doi: 10.1007/s00702-006-0512-8. Epub 2006 Jul 13. J Neural Transm (Vienna). 2006. PMID: 16835692 Review.
• Mechanistic Insights Expatiating the Redox-Active-Metal-Mediated Neuronal Degeneration in Parkinson's Disease.
  Behl T, Madaan P, Sehgal A, Singh S, Anwer MK, Makeen HA, Albratty M, Mohan S, Bungau S. Behl T, et al. Int J Mol Sci. 2022 Jan 8;23(2):678. doi: 10.3390/ijms23020678. Int J Mol Sci. 2022. PMID: 35054862 Free PMC article. Review.
• Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.
  Zhou C, Huang Y, Przedborski S. Zhou C, et al. Ann N Y Acad Sci. 2008 Dec;1147:93-104. doi: 10.1196/annals.1427.023. Ann N Y Acad Sci. 2008. PMID: 19076434 Free PMC article. Review.
• The kinase domain of mitochondrial PINK1 faces the cytoplasm.
  Zhou C, Huang Y, Shao Y, May J, Prou D, Perier C, Dauer W, Schon EA, Przedborski S. Zhou C, et al. Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):12022-7. doi: 10.1073/pnas.0802814105. Epub 2008 Aug 7. Proc Natl Acad Sci U S A. 2008. PMID: 18687899 Free PMC article.
• CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy.
  Sardi SP, Clarke J, Kinnecom C, Tamsett TJ, Li L, Stanek LM, Passini MA, Grabowski GA, Schlossmacher MG, Sidman RL, Cheng SH, Shihabuddin LS. Sardi SP, et al. Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12101-6. doi: 10.1073/pnas.1108197108. Epub 2011 Jul 5. Proc Natl Acad Sci U S A. 2011. PMID: 21730160 Free PMC article.

Publication types

MeSH terms

Substances

Grants and funding

• NS42269/NS/NINDS NIH HHS/United States
• P01 NS11766-27A1/NS/NINDS NIH HHS/United States
• P50 NS38370/NS/NINDS NIH HHS/United States
• R01 AG021617-01/AG/NIA NIH HHS/United States
• R01 NS38586/NS/NINDS NIH HHS/United States
• R29 NS37345/NS/NINDS NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal